SCHEMBL24118386

SCHEMBL24118386

C=C(CCNC(=O)c1cc(F)c(F)c(F)c1)[C@H](C)C(=O)Nc1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 3/20 0.42
▸ IDO1 P14902 2/20 0.41
▸ SNCA P37840 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ NAMPT P43490 1/20 0.39
▸ HDAC3 O15379 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ NCOR2 Q9Y618 2/20 0.39
▸ GCG P01275 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ RHOC P08134 1/20 0.38
▸ RHOA P61586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118272 0.91 MEN1 (0.44) MEN1KMT2APOLBIDO1SNCA
SCHEMBL24117949 0.90 IDO1 (0.53) MEN1KMT2APOLBIDO1NAMPT
SCHEMBL24118244 0.88 ALDH1A1 (0.51) MEN1KMT2APOLBIDO1NAMPT
SCHEMBL24118064 0.87 IDO1 (0.46) MEN1KMT2APOLBIDO1NAMPT
SCHEMBL24118062 0.86 IDO1 (0.54) MEN1KMT2APOLBIDO1GCG
SCHEMBL24118311 0.86 ALDH1A1 (0.46) MEN1KMT2APOLBIDO1CYP1A2
SCHEMBL24118073 0.86 ALDH1A1 (0.46) MEN1KMT2APOLBIDO1CYP1A2
SCHEMBL24118248 0.83 POLB (0.56) MEN1KMT2APOLBHDAC3HDAC1
SCHEMBL24117930 0.82 CYP1A2 (0.49) MEN1KMT2APOLBIDO1CYP1A2
SCHEMBL24118254 0.82 FPR2 (0.48) MEN1KMT2APOLBCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors MERCK SHARP & DOHME CORP. (US) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors IDO1, IDO2, TPH1 MEN1 1667/4885KMT2A 1464/4885POLB 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback